Volume Spike Investor

Medarex Inc. (NASDAQ: MEDX) is very unusual to see as a volume leader but it is the most active in pre-market trading.  That likely will not last as it is likely merger-arb related after the Hart-Scott-Rodino merger review period for the Bristol-Myers Squibb (NYSE: BMY) has expired. At 9:05 AM EST we have shares up 0.5% but oin almost 800,000 shares.  No terms of the deal have changed. -JON OGG